Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Erythema, Pain, Platelet count decreased, Pruritus
Clinical narrative: Lung bleeding; Rash on her leg came back; Redness; Tenderness; Bruise; Purple extending bruise-like rash on the left leg; Itching; Painful; This spontaneous case was reported by a physician and describes the occurrence of PULMONARY HAEMORRHAGE (Lung bleeding) and RASH (Rash on her leg came back) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Surgery.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PULMONARY HAEMORRHAGE (Lung bleeding) (seriousness criteria hospitalization prolonged and medically significant), RASH (Rash on her leg came back) (seriousness criterion hospitalization prolonged), ERYTHEMA (Redness), TENDERNESS (Tenderness), CONTUSION (Bruise), RASH (Purple extending bruise-like rash on the left leg), PRURITUS (Itching) and PAIN (Painful). The patient was hospitalized on sometime in 2021 due to PULMONARY HAEMORRHAGE and RASH. The patient was treated with Surgery (Grafted the vein from right under for the bypass.) for Pulmonary haemorrhage. At the time of the report, PULMONARY HAEMORRHAGE (Lung bleeding), RASH (Rash on her leg came back), ERYTHEMA (Redness), TENDERNESS (Tenderness), CONTUSION (Bruise), PRURITUS (Itching) and PAIN (Painful) outcome was unknown and RASH (Purple extending bruise-like rash on the left leg) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Platelet count decreased: 90-110 (Low) Platelets are trending on the lower side 90-110..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment for the event included blood transfusions.  On an unknown date the patient experienced, ERYTHEMA (Redness), TENDERNESS (Tenderness), CONTUSION (Bruise), RASH (Purple extending bruise-like rash on the left leg), PRURITUS (Itching) and PAIN (Painful). On an unknown date she had major heart surgery since and experienced RASH (Rash on her leg came back) (seriousness criterion hospitalization prolonged) and PULMONARY HAEMORRHAGE (Lung bleeding) (seriousness criteria hospitalization prolonged and medically significant). The rash on her leg came back during the postop course. It was in the exact location. Unfortunately they grafted the vein from right under for the bypass. She was in ICU for the last 6 weeks with unknown etiology of lung bleeding.  Based on the current available information and temporal association between the use of the product and the start date of the events  Erythema, Tenderness, Contusion, Rash, Pruritus and Pain, a causal relationship cannot be excluded. As for the serious events Pulmonary Haemorrhage and Rash requiring hospitalization, very limited information regarding these events has been provided at this time.  Further information has been requested.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Follow-up received included laboratory investigations, new events, seriousness and treatment details.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events  Erythema, Tenderness, Contusion, Rash, Pruritus and Pain, a causal relationship cannot be excluded. As for the serious events Pulmonary Haemorrhage and Rash requiring hospitalization, very limited information regarding these events has been provided at this time.  Further information has been requested.